23andme Holding Intrinsic Stock Value – 23andMe Reports Limited Impact from Data Breach, Affecting Less than 0.1% of Accounts
December 11, 2023
🌧️Trending News
23ANDME HOLDING ($NASDAQ:ME), a leading consumer genetics and research-based company, has recently reported a limited impact from a data breach that affected less than 0.1% of their user accounts. The company quickly responded to the data breach, confirming that only 0.1% of their user accounts were affected. 23ANDME HOLDING is working with relevant authorities to identify the cause of the breach, as well as take measures to further secure their systems. They’ve emphasized that no financial information or genetic results were compromised and that they are taking steps to prevent future issues.
The data breach is not expected to have any significant impact on 23ANDME HOLDING’s operations. It is reassuring to know that their robust security protocols have effectively protected the majority of their users from any potential harm. They remain committed to providing their customers with safe and secure services.
Analysis – 23andme Holding Intrinsic Stock Value
At GoodWhale, we have been analyzing the wellbeing of 23ANDME HOLDING. Our proprietary Valuation Line has calculated the intrinsic value of their stock to be around $3.4. However, the 23ANDME HOLDING stock is currently being traded at $1.0, suggesting that the market is undervaluing their share by 70.3%. By investing in 23ANDME HOLDING now, investors have a great opportunity to benefit from the potential upside of its share price. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for 23andme Holding. More…
| Total Revenues | Net Income | Net Margin |
| 270.18 | -335.95 | -121.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for 23andme Holding. More…
| Operations | Investing | Financing |
| -145.89 | -11.82 | 4.07 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for 23andme Holding. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 801.23 | 175.98 | 1.31 |
Key Ratios Snapshot
Some of the financial key ratios for 23andme Holding are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -0.7% | – | -128.8% |
| FCF Margin | ROE | ROA |
| -58.4% | -33.4% | -27.1% |
Peers
The company offers a range of tests, including those for ancestry, health, and wellness. Its competitors include IQVIA Holdings Inc, Illumina Inc, and Avricore Health Inc.
– IQVIA Holdings Inc ($NYSE:IQV)
In 2022, IQVIA Holdings Inc had a market capitalization of $40.44 billion and a return on equity of 21.52%. The company provides data, information and technology solutions that help customers drive healthcare insights and solutions.
– Illumina Inc ($NASDAQ:ILMN)
Illumina Inc has a market cap of 34.93B as of 2022, a Return on Equity of -29.49%. The company is a provider of sequencing and array-based solutions for genetic analysis. The company’s products are used by researchers, physicians, patients and parents to make better decisions about health, agriculture, pharmaceuticals, research and many other areas.
– Avricore Health Inc ($TSXV:AVCR)
Avricore Health Inc is a Canadian biotechnology company that develops and commercializes products for the early detection and prevention of chronic disease. The company has a market cap of 25.4 million as of 2022 and a return on equity of -46.21%. Avricore’s products are based on its proprietary technology, which uses a combination of blood tests and genetic tests to identify individuals at risk for developing chronic diseases such as heart disease, stroke, and cancer.
Summary
23andMe Holding Inc is a biotechnology company that has seen a notable rise in its stock price as of late. This can be attributed to their recent data breach announcement, which revealed that only 0.1% of user accounts were affected. Investors are likely reassured by this news and the company’s ability to secure its data.
Overall, 23andMe Holding Inc appears to be a reliable investment option that has strong security measures in place. With a promising outlook and steady stock performance, investing in 23andMe Holding Inc could be a wise choice.
